{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:55:40Z","timestamp":1790902540888,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","award":["LJ222510162016"],"award-info":[{"award-number":["LJ222510162016"]}],"id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008844","name":"Liaoning University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2025-Dxkjc-15-01"],"award-info":[{"award-number":["2025-Dxkjc-15-01"]}],"id":[{"id":"10.13039\/501100008844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008844","name":"Liaoning University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["zyzx2404"],"award-info":[{"award-number":["zyzx2404"]}],"id":[{"id":"10.13039\/501100008844","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bioadv.2026.215183","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:39:34Z","timestamp":1789400374000},"page":"215183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Stepwise progressive dual-regulated micelles enhance the therapeutic efficacy of hepatocellular carcinoma by remodeling the tumor microenvironment"],"prefix":"10.1016","volume":"190","author":[{"given":"Muhan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuetao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bioadv.2026.215183_bb0005","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.bioadv.2026.215183_bb0010","article-title":"Hepatocellular carcinoma: Epidemiology, diagnosis and treatment","volume":"7","author":"Mauro","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.bioadv.2026.215183_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/10732748241310573","article-title":"Burden of hepatocellular carcinoma and its underlying etiologies in China, 1990-2021: findings from the Global Burden of Disease Study 2021","volume":"31","author":"Long","year":"2024","journal-title":"Cancer Control"},{"issue":"3","key":"10.1016\/j.bioadv.2026.215183_bb0020","first-page":"271","article-title":"Global liver cancer incidence and mortality and future trends from 2000 to 2020: GLOBOCAN data analysis","volume":"31","author":"Wang","year":"2023","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"Suppl","key":"10.1016\/j.bioadv.2026.215183_bb0025","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.3350\/cmh.2024.0824","article-title":"Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment","volume":"31","author":"Hwang","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"issue":"7938","key":"10.1016\/j.bioadv.2026.215183_bb0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","article-title":"Liver tumour immune microenvironment subtypes and neutrophil heterogeneity","volume":"612","author":"Xue","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bioadv.2026.215183_bb0035","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.32740","article-title":"The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma","volume":"77","author":"Donne","year":"2023","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.bioadv.2026.215183_bb0040","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","article-title":"The immunological and metabolic landscape in primary and metastatic liver cancer","volume":"21","author":"Li","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.bioadv.2026.215183_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008721","article-title":"POSTN(+) cancer-associated fibroblasts determine the efficacy of immunotherapy in hepatocellular carcinoma","volume":"12","author":"Wang","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215183_bb0050","first-page":"5","article-title":"MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies","volume":"12","author":"Tang","year":"2025","journal-title":"Mil. Med. Res."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215183_bb0055","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1186\/s12951-025-03874-1","article-title":"Self-activated prodrug nanocomposites reprogramming lactic acid metabolism to initiate acidosis-endoplasmic reticulum stress cascade and potentiate immunogenic cell death for enhanced liver cancer therapy","volume":"23","author":"Chen","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"13","key":"10.1016\/j.bioadv.2026.215183_bb0060","article-title":"Immunogenic cell death in hematological malignancy therapy","volume":"10","author":"Liu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"22","key":"10.1016\/j.bioadv.2026.215183_bb0065","article-title":"Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.bioadv.2026.215183_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2025.124617","article-title":"Qualitative and quantitative analyses of chemical components in different parts of Marsdenia cavaleriei","volume":"1259","author":"Nan","year":"2025","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.bioadv.2026.215183_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119908","article-title":"The central role of ferroptosis-induced therapy mediated by tenacissoside H in anaplastic thyroid cancer","volume":"348","author":"He","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215183_bb0080","doi-asserted-by":"crossref","DOI":"10.1177\/15593258211011023","article-title":"Tenacissoside H induces autophagy and radiosensitivity of hepatocellular carcinoma cells by PI3K\/Akt\/mTOR signaling pathway","volume":"19","author":"Lin","year":"2021","journal-title":"Dose-Response"},{"key":"10.1016\/j.bioadv.2026.215183_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176401","article-title":"Tenacissoside H repressed the progression of glioblastoma by inhibiting the PI3K\/Akt\/mTOR signaling pathway","volume":"968","author":"Dong","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215183_bb0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jgr.2022.09.011","article-title":"The ways for ginsenoside Rh2 to fight against cancer: the molecular evidences in vitro and in vivo","volume":"47","author":"Hu","year":"2023","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.bioadv.2026.215183_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113912","article-title":"Role of ginsenoside Rh2 in tumor therapy and tumor microenvironment immunomodulation","volume":"156","author":"Xiaodan","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215183_bb0100","first-page":"179","article-title":"Anticancer Effects of Ginsenoside Rh2: A Systematic Review","volume":"15","author":"He","year":"2022","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.bioadv.2026.215183_bb0105","article-title":"Remodeling the tumor immune microenvironment through hydrogel encapsulated G-Rh2 in situ vaccine and systemic immunotherapy","volume":"29","author":"Li","year":"2024","journal-title":"Mater. Today Bio"},{"issue":"10","key":"10.1016\/j.bioadv.2026.215183_bb0110","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1021\/acs.molpharmaceut.4c00437","article-title":"Tumor-Targeted CO Nanodelivery System Design and Therapy for Hepatocellular Carcinoma","volume":"21","author":"Zhang","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioadv.2026.215183_bb0115","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.2147\/IJN.S363456","article-title":"Current strategies for the treatment of hepatocellular carcinoma by modulating the tumor microenvironment via nano-delivery systems: a review","volume":"17","author":"Huang","year":"2022","journal-title":"Int. J. Nanomedicine"},{"issue":"Pt 4","key":"10.1016\/j.bioadv.2026.215183_bb0120","article-title":"Rational design of pH-responsive nano-delivery system with improved biocompatibility and targeting ability from cellulose nanocrystals via surface polymerization for intracellular drug delivery","volume":"281","author":"Li","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215183_bb0125","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1186\/s12967-025-06508-0","article-title":"Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements","volume":"23","author":"Wang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.bioadv.2026.215183_bb0130","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.apsb.2020.11.024","article-title":"Emerging nanomedicine-based therapeutics for hematogenous metastatic cascade inhibition: Interfering with the crosstalk between \u201cseed and soil\u201d","volume":"11","author":"Wu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.bioadv.2026.215183_bb0135","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.trecan.2022.11.002","article-title":"Biophysical determinants of cancer organotropism","volume":"9","author":"Azubuike","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bioadv.2026.215183_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214636","article-title":"Enhanced permeability and retention (EPR) effect: Advances in nanomedicine for improved tumor targeting","volume":"181","author":"Khan","year":"2026","journal-title":"Biomater. Adv."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215183_bb0145","article-title":"Tumor-Microenvironment-Responsive Nanomedicine for Enhanced Cancer Immunotherapy","volume":"9","author":"Peng","year":"2022","journal-title":"Adv Sci (Weinh)"},{"issue":"22","key":"10.1016\/j.bioadv.2026.215183_bb0150","article-title":"Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with alphaPD-L1 for enhanced cancer immunotherapy","volume":"35","author":"Guo","year":"2023","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.bioadv.2026.215183_bb0155","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.7150\/thno.121977","article-title":"Design of prodrugs with reactive oxygen species as activators and their application in tumor therapy","volume":"16","author":"Xing","year":"2026","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.bioadv.2026.215183_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27061775","article-title":"Recent advances in glycyrrhetinic acid-functionalized biomaterials for liver cancer-targeting therapy","volume":"27","author":"Speciale","year":"2022","journal-title":"Molecules"},{"issue":"24","key":"10.1016\/j.bioadv.2026.215183_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28248131","article-title":"Glycyrrhetinic Acid Receptor-Mediated Zeolitic Imidazolate Framework-8 Loaded Doxorubicin as a Nanotherapeutic System for Liver Cancer Treatment","volume":"28","author":"Mi","year":"2023","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bioadv.2026.215183_bb0170","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/acs.molpharmaceut.2c00842","article-title":"Dual-Ligand-Functionalized Liposomes Based on Glycyrrhetinic Acid and cRGD for Hepatocellular Carcinoma Targeting and Therapy","volume":"20","author":"Qiu","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioadv.2026.215183_bb0175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2147\/IJN.S470219","article-title":"Tumor microenvironment responsive key nanomicelles for effective against invasion and metastasis in ovarian cancer using mice model","volume":"20","author":"Liu","year":"2025","journal-title":"Int. J. Nanomedicine"},{"issue":"47","key":"10.1016\/j.bioadv.2026.215183_bb0180","article-title":"The Immune Microenvironment in Liver Cancer: From Analysis to Targeting","volume":"12","author":"Lan","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.bioadv.2026.215183_bb0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","article-title":"Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy","volume":"470","author":"Lei","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioadv.2026.215183_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114659","article-title":"Anti-PD-L1 biomimetic nanobubbles for ultrasound-triggered reprogramming of cold hepatocellular carcinoma for immunotherapy","volume":"392","author":"Tu","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.215183_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105693","article-title":"Size-shrinkable and protein kinase Calpha-recognizable nanoparticles for deep tumor penetration and cellular internalization","volume":"159","author":"Ma","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"issue":"46","key":"10.1016\/j.bioadv.2026.215183_bb0200","doi-asserted-by":"crossref","first-page":"30336","DOI":"10.1021\/acsomega.0c05076","article-title":"Amphiphilic mPEG-Modified Oligo-Phenylalanine Nanoparticles Chemoenzymatically Synthesized via Papain","volume":"5","author":"Wang","year":"2020","journal-title":"ACS Omega"},{"issue":"9","key":"10.1016\/j.bioadv.2026.215183_bb0205","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1021\/acs.nanolett.3c00449","article-title":"Role of Micelle Size in Cell Transcytosis-Based Tumor Extravasation, Infiltration, and Treatment Efficacy","volume":"23","author":"Fan","year":"2023","journal-title":"Nano Lett."},{"issue":"4","key":"10.1016\/j.bioadv.2026.215183_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/polym15040946","article-title":"Stabilized Reversed Polymeric Micelles as Nanovector for Hydrophilic Compounds","volume":"15","author":"Gagliardi","year":"2023","journal-title":"Polymers (Basel)"},{"issue":"17","key":"10.1016\/j.bioadv.2026.215183_bb0215","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1039\/D4BM00647J","article-title":"Reactive oxygen species driven prodrug-based nanoscale carriers for transformative therapies","volume":"12","author":"Vasvani","year":"2024","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bioadv.2026.215183_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113439","article-title":"Preparation and characterization of solid lipid nanoparticles incorporating bioactive coumarin analogues as photosensitizing agents","volume":"229","author":"Katopodi","year":"2023","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bioadv.2026.215183_bb0225","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.2147\/IJN.S394953","article-title":"Customizable dual-fluorescent nanoparticles for tracing and quantifying of cell transport","volume":"18","author":"Ta","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"8","key":"10.1016\/j.bioadv.2026.215183_bb0230","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41419-024-06939-5","article-title":"Oxidative cell death in cancer: mechanisms and therapeutic opportunities","volume":"15","author":"An","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioadv.2026.215183_bb0235","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5381692","article-title":"Understanding of ROS-inducing strategy in anticancer therapy","volume":"2019","author":"Kim","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"8","key":"10.1016\/j.bioadv.2026.215183_bb0240","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1158\/1535-7163.MCT-24-1098","article-title":"Repurposing the DNA Labeling Agent EdU for Therapy against Heterogeneous Patient Glioblastoma","volume":"24","author":"Kaanoglu","year":"2025","journal-title":"Mol. Cancer Ther."},{"issue":"24","key":"10.1016\/j.bioadv.2026.215183_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413521","article-title":"Wanted: Dead or Alive Cells with Propidium Iodide Staining in Liver Tissue","volume":"25","author":"Krapoth","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215183_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167557","article-title":"The IP(3)R inhibitor desmethylxestospongin B reduces tumor cell migration, invasion and metastasis by impairing lysosome acidification and beta1-integrin recycling","volume":"1871","author":"Bustos","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"12","key":"10.1016\/j.bioadv.2026.215183_bb0255","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting immunogenic cell death in cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bioadv.2026.215183_bb0260","article-title":"Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioadv.2026.215183_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121137","article-title":"M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages","volume":"278","author":"Gunassekaran","year":"2021","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.bioadv.2026.215183_bb0270","article-title":"Macrophage Polarization and Reprogramming in Acute Inflammation: A Redox Perspective","volume":"11","author":"Perez","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.bioadv.2026.215183_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103059","article-title":"A novel role for the ROS-ATM-Chk2 axis mediated metabolic and cell cycle reprogramming in the M1 macrophage polarization","volume":"70","author":"Li","year":"2024","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215183_bb0280","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13045-024-01559-0","article-title":"Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy","volume":"17","author":"Toledo","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.bioadv.2026.215183_bb0285","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.bioadv.2026.215183_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/cells14100741","article-title":"Tumor-Associated Macrophages: Polarization, Immunoregulation, and Immunotherapy","volume":"14","author":"Saeed","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215183_bb0295","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"46","key":"10.1016\/j.bioadv.2026.215183_bb0300","doi-asserted-by":"crossref","first-page":"19399","DOI":"10.1039\/D1NR05824J","article-title":"A DiR loaded tumor targeting theranostic cisplatin-icodextrin prodrug nanoparticle for imaging guided chemo-photothermal cancer therapy","volume":"13","author":"Guan","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.bioadv.2026.215183_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1430187","article-title":"TGF-beta and TNF-alpha interaction promotes the expression of MMP-9 through H3K36 dimethylation: implications in breast cancer metastasis","volume":"15","author":"Kochumon","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioadv.2026.215183_bb0310","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2592962","article-title":"Prognostic and immunological roles of MMP-9 in pan-cancer","volume":"2022","author":"Zeng","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bioadv.2026.215183_bb0315","article-title":"Metabolic reprogramming in hepatocellular carcinoma: mechanisms of immune evasion and therapeutic implications","volume":"16","author":"Gao","year":"2025","journal-title":"Front. Immunol."},{"issue":"48","key":"10.1016\/j.bioadv.2026.215183_bb0320","doi-asserted-by":"crossref","first-page":"20403","DOI":"10.1039\/D4SC06305H","article-title":"Bimodal accurate H(2)O(2) regulation to equalize tumor-associated macrophage repolarization and immunogenic tumor cell death elicitation","volume":"15","author":"Zhao","year":"2024","journal-title":"Chem. Sci."},{"issue":"5","key":"10.1016\/j.bioadv.2026.215183_bb0325","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","article-title":"Macrophage-Based Approaches for Cancer Immunotherapy","volume":"81","author":"Anderson","year":"2021","journal-title":"Cancer Res."},{"issue":"45","key":"10.1016\/j.bioadv.2026.215183_bb0330","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031399","article-title":"Short-term prognosis for hepatocellular carcinoma patients with lung metastasis: A retrospective cohort study based on the SEER database","volume":"101","author":"Chen","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bioadv.2026.215183_bb0335","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.critrevonc.2017.11.010","article-title":"E-cadherin: Its dysregulation in carcinogenesis and clinical implications","volume":"121","author":"Wong","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"10","key":"10.1016\/j.bioadv.2026.215183_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101118","article-title":"The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges","volume":"8","author":"Loh","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215183_bb0345","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbrc.2019.04.063","article-title":"Matrine suppresses lung metastasis of human hepatocellular carcinoma by directly targeting matrix metalloproteinase-9","volume":"515","author":"Zhang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioadv.2026.215183_bb0350","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"36","key":"10.1016\/j.bioadv.2026.215183_bb0355","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202000673","article-title":"Safety considerations of cancer nanomedicine-a key step toward translation","volume":"16","author":"Liu","year":"2020","journal-title":"Small"}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826004838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826004838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:24:01Z","timestamp":1790900641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950826004838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":71,"alternative-id":["S2772950826004838"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215183","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stepwise progressive dual-regulated micelles enhance the therapeutic efficacy of hepatocellular carcinoma by remodeling the tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"215183"}}